Churchill Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,703
Closed -$18.3M 161
2024
Q3
$18.3M Buy
20,703
+11,746
+131% +$10.6M 0.21% 41
2024
Q2
$8.11M Buy
8,957
+68
+0.8% +$54.4K 0.1% 84
2024
Q1
$6.92M Buy
+8,889
New +$6.33M 0.09% 91
2023
Q1
Sell
-34,380
Closed -$12.6M 135
2022
Q4
$12.6M Sell
34,380
-1,671
-5% -$592K 0.3% 44
2022
Q3
$11.7M Buy
+36,051
New +$11.4M 0.31% 41
2020
Q4
Sell
-18,202
Closed -$2.69M 141
2020
Q3
$2.69M Sell
18,202
-2,219
-11% -$343K 0.07% 107
2020
Q2
$3.35M Buy
20,421
+662
+3% +$102K 0.1% 85
2020
Q1
$2.74M Sell
19,759
-305
-2% -$41.9K 0.14% 77
2019
Q4
$2.64M Buy
+20,064
New +$2.33M 0.05% 105
2015
Q4
Sell
-70,294
Closed -$5.88M 128
2015
Q3
$5.88M Sell
70,294
-3,524
-5% -$298K 0.47% 44
2015
Q2
$6.16M Sell
73,818
-3,087
-4% -$235K 0.22% 59
2015
Q1
$5.59M Sell
76,905
-2,023
-3% -$144K 0.19% 72
2014
Q4
$5.45M Sell
78,928
-3,460
-4% -$234K 0.22% 63
2014
Q3
$5.34M Sell
82,388
-2,835
-3% -$179K 0.22% 59
2014
Q2
$5.3M Buy
85,223
+7,976
+10% +$476K 0.24% 57
2014
Q1
$4.55M Buy
+77,247
New +$4.31M 0.18% 57
2013
Q4
Sell
-7,921
Closed -$399K 198
2013
Q3
$399K Sell
7,921
-60,787
-88% -$3.18M 0.02% 146
2013
Q2
$3.38M Buy
+68,708
New +$3.74M 0.16% 44

Other funds holding LLY

Churchill Management's LLY Position: Q4 2024 in Review

Churchill Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 20,703 shares — an estimated $18.3M sold.

Churchill Management first reported a position in LLY in Q2 2013 and held it in 18 quarters. The position peaked at $18.3M in Q3 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Churchill Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Churchill Management sold 20,703 Eli Lilly shares in Q4 2024, an estimated $18.3M.
  • Churchill Management first reported a position in Eli Lilly in Q2 2013 and held it in 18 quarters.
  • Churchill Management's Eli Lilly position peaked at $18.3M in Q3 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Churchill Management's 13F filing for Q4 2024, filed 14 Jan 2025.